Status: current, Defined. Date: 31-May 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1903961000168112 | terbinafine 125 mg tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1903971000168118 | terbinafine 125 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| terbinafine 125 mg tablet | Is a | terbinafine | true | Inferred relationship | Some | ||
| terbinafine 125 mg tablet | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| terbinafine 125 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| terbinafine 125 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 29564829 | |
| terbinafine 125 mg tablet | has Australian BoSS | terbinafine | true | Inferred relationship | Some | 29564828 | |
| terbinafine 125 mg tablet | has intended active ingredient | terbinafine | true | Inferred relationship | Some | 29564828 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lamisil 125 mg tablet | Is a | True | terbinafine 125 mg tablet | Inferred relationship | Some | |
| terbinafine 125 mg tablet, 28 | has MPUU | True | terbinafine 125 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR